Chemoinformaics analysis of 2,5-Dihydroxyterephthalic acid
| Molecular Weight | 198.13 | nRot | 2 |
| Heavy Atom Molecular Weight | 192.082 | nRig | 8 |
| Exact Molecular Weight | 198.016 | nRing | 1 |
| Solubility: LogS | -2.359 | nHRing | 0 |
| Solubility: LogP | 1.919 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 22.1728 |
| nHD | 4 | BPOL | 7.75524 |
| QED | 0.514 |
| Synth | 2.029 |
| Natural Product Likeliness | 0.394 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.497 |
| CACO-2 | -5.912 |
| MDCK | 0.00000357 |
| BBB | 0.165 |
| PPB | 0.629715 |
| VDSS | 0.343 |
| FU | 0.301211 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.031 |
| CYP2c9-inh | 0.181 |
| CYP2c9-sub | 0.042 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.068 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.008 |
| CL | 2.284 |
| T12 | 0.951 |
| hERG | 0.026 |
| Ames | 0.016 |
| ROA | 0.097 |
| SkinSen | 0.348 |
| Carcinogencity | 0.008 |
| EI | 0.584 |
| Respiratory | 0.812 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.885616 |